Yongjin Hao

Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.

T. Yang, Sheng Tian, Jingrui Wang, 2021, European journal of medicinal chemistry.

Design, synthesis, and evaluation of novel CXCR4 antagonists based on an aminoquinoline template.

L. Luo, Xiaohu Zhang, Haikuo Ma, 2020, Bioorganic chemistry.

A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis

Feng Ma, Sheng Tian, Xiaohu Zhang, 2022, Blood.

Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2022, Bioorganic chemistry.

Permeability Damage Mechanism and Evolution of Gas-Bearing Coal Seams Induced by Drilling Fluid

Yongjiang Luo, Yongjin Hao, L. Kong, 2023, Natural Resources Research.

Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2023, European journal of medicinal chemistry.

Design, synthesis, evaluation and optimization of potent IRAK4 inhibitors alleviating production of inflammatory cytokines in LPS-induced SIRS model.

Sheng Tian, Xiaohu Zhang, Haikuo Ma, 2023, Bioorganic chemistry.